Genocea Biosciences Inc (GNCA) Return on Assets ROA from the first quarter of 2022 to first quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genocea Biosciences Inc   (NASDAQ: GNCA)


Genocea Biosciences Inc 's ROA from the first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Genocea Biosciences Inc 's ROA in the first quarter of 2022?
Genocea Biosciences Inc recorded a cumulative net loss of $-37 million during 12 months ending in the first quarter of 2022, resulting in a negative return on assets (ROA) of -62.75%.

However, within the Healthcare sector 905 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2022 quarter, so far to 5119, from total ROA ranking in the fourth quarter of 2021 at 5277.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Total Assets Change -53.79 % -43.18 % -38.87 % 90.99 % 85.74 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -37 -33 -35 -36 -43
Return On Assets (TTM) -62.75 % -47.05 % -42.99 % -39.16 % -52.07 %
GNCA's Total Ranking # 5119 # 5277 # 4305 # 4246 # 4326
Total Assets (TTM) in million 39 56 65 77 84
Seq. Total Assets Change -30.69 % -13.79 % -16.11 % -7.81 % -14.78 %
Seq. Net Income Change - - - - -

GNCA's 5 Years Annual ROA >> Back to GNCA Management Effectiveness >> Compare GNCA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 137
Sector # 906
Overall # 4999

Return On Assets Statistics
High Average Low
-38.41 %
-71.24 %
-162.83 %
(Jun 30 2016)   (Mar 31 2018)





Financial Statements
Genocea Biosciences Inc 's Assets $ 39 million GNCA's Balance sheet
Genocea Biosciences Inc 's Income $ -16 million Quarterly GNCA's Income Statement
GNCA's Income by Division See GNCA's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change -43.18 % 87.21 % 69.09 % 77.92 % -74.98 %
Total Assets in million 56 98 53 31 17
Y / Y Net Income Change - - - - -
Net Income in million -33 -44 -39 -28 -57
Annual Return On Assets -59.31 % -44.38 % -74.03 % -89.38 % -324.28 %

GNCA's 5 Years Annual ROA >> Back to GNCA Management Effectiveness >> Compare GNCA ROA to its Competitors



More Return On Assets Ratios
GNCA's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GNCA's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GNCA's Competitors
Subscribers only: Roa for Genocea Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for GNCA's Customers

You may also want to know
GNCA's Roi GNCA's Inventory Turnover Ratio GNCA's Growth Rates GNCA's Dividend Comparisons
GNCA's Profitability Ratios GNCA's Asset Turnover Ratio GNCA's Dividend Growth
GNCA's Roe GNCA's Valuation Ratios GNCA's Financial Strength Ratios GNCA's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.